Restoration of acetylcholinesterase activity by Euphorbia hirta in discrete brain regions of chronically stressed rats

References

• Aguirre-Hernandez E, Rosas-Acevedo H, Soto-Hernandez M, Martinez AL, Moreno J, Gonzalez-Trujano ME (2007): Bioactivity-guided isolation of beta-sitosterol and some fatty acids as active compounds in the anxiolytic and sedative effects of Tilia americana var. mexicana. Planta Med 73: 1148–1155.
   PubMed Web of Science ®Google Scholar
• Anuradha H, Srikumar BN, Shankaranarayana Rao BS, Lakshmana M (2008): Euphorbia hirta reverses chronic stress-induced anxiety and mediates its action through the GABAA receptor benzodiazepine receptor-Cl− channel complex. J Neural Transm 115: 35–42.
   PubMed Web of Science ®Google Scholar
• Barros M, Giorgetti M, Souto AA, Vilela G, Santos K, Boas NV, Tomaz C (2007): Persistent anxiety-like behavior in marmosets following a recent predatory stress condition: reversal by diazepam. Pharmacol Biochem Behav 86: 705–711.
   PubMed Web of Science ®Google Scholar
• Bodnoff SR, Humphreys AG, Lehman JC, Diamond DM, Rose GM, Meaney MJ (1995): Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 15: 61–69.
   PubMed Web of Science ®Google Scholar
• Brioni JD, O’Neill AB, Kim DJ, Decker MW (1993): Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 238: 1–8.
   PubMed Web of Science ®Google Scholar
• Brown E, Hurd NS, McCall S, Ceremuga TE (2007): Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J 75: 333–337.
   PubMedGoogle Scholar
• Carlini EA (2003): Plants and the central nervous system. Pharmacol Biochem Behav 75: 501–512.
   PubMed Web of Science ®Google Scholar
• Degroot A, Wade M, Salhoff C, Davis RJ, Tzavara ET, Nomikos GG (2004): Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: Reversal by chlordiazepoxide. Eur J Pharmacol 493: 103–109.
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961): A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95.
   PubMed Web of Science ®Google Scholar
• File SE, Kenny PJ, Cheeta S (2000): The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 66: 65–72.
   PubMedGoogle Scholar
• Gold PE (2003): Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 80: 194–210.
   PubMed Web of Science ®Google Scholar
• Govindarajan A, Shankaranarayana Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S, Chattarji S (2006): Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103: 13208–13213.
   PubMed Web of Science ®Google Scholar
• Kennedy DO, Pace S, Haskell C, Okello EJ, Milne A, Scholey AB (2006): Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology 31: 845–852.
   PubMed Web of Science ®Google Scholar
• Kienzle-Horn S (2002): Herbal medicines for neurological diseases. Curr Opin Investig Drugs 3: 763–767.
   PubMedGoogle Scholar
• Lamprea MR, Cardenas FP, Silveira R, Walsh TJ, Morato S (2003): Effects of septal cholinergic lesion on rat exploratory behavior in an open-field. Braz J Med Biol Res 36: 233–238.
   PubMedGoogle Scholar
• Lewis PR, Shute CC, Silver A (1967): Confirmation from choline acetylase analyses of a massive cholinergic innervation to the rat hippocampus. J Physiol 191: 215–224.
   PubMedGoogle Scholar
• Magarinos AM, McEwen BS (1995): Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69: 89–98.
   PubMed Web of Science ®Google Scholar
• McEwen BS (2000): The neurobiology of stress: From serendipity to clinical relevance. Brain Res 886: 172–189.
   PubMed Web of Science ®Google Scholar
• McLay RN, Freeman SM, Zadina JE (1998): Chronic corticosterone impairs memory performance in the Barnes maze. Physiol Behav 63: 933–937.
   PubMedGoogle Scholar
• McNaughton N, Gray JA (2000): Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord 61: 161–176.
   PubMed Web of Science ®Google Scholar
• Mellgren SI, Srebro B (1973): Changes in acetylcholinesterase and distribution of degenerating fibres in the hippocampal region after septal lesions in the rat. Brain Res 52: 19–36.
   PubMed Web of Science ®Google Scholar
• Pung T, Klein B, Blodgett D, Jortner B, Ehrich M (2006): Examination of concurrent exposure to repeated stress and chlorpyrifos on cholinergic, glutamatergic, and monoamine neurotransmitter systems in rat forebrain regions. Int J Toxicol 25: 65–80.
   PubMedGoogle Scholar
• Rajarao SJ, Platt B, Sukoff SJ, Lin Q, Bender CN, Nieuwenhuijsen BW, Ring RH, Schechter LE, Rosenzweig-Lipson S, Beyer CE (2007): Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon. Neuropeptides 41: 307–320.
   PubMedGoogle Scholar
• Ramkumar K, Srikumar BN, Shankaranarayana Rao BS, Raju TR (2008): Self-stimulation rewarding experience restores stress-induced CA3 dendritic atrophy, spatial memory deficits and alterations in the levels of neurotransmitters in the hippocampus. Neurochem Res 33: 1651–1662.
   PubMedGoogle Scholar
• Roche M, Commons KG, Peoples A, Valentino RJ (2003): Circuitry underlying regulation of the serotonergic system by swim stress. J Neurosci 23: 970–977.
   PubMedGoogle Scholar
• Rodgers RJ, Cole JC (1995): Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behav Pharmacol 6: 283–289.
   PubMedGoogle Scholar
• Saeed SA, Bloch RM, Antonacci DJ (2007): Herbal and dietary supplements for treatment of anxiety disorders. Am Fam Physician 76: 549–556.
   PubMed Web of Science ®Google Scholar
• Sienkiewicz-Jarosz H, Czlonkowska AI, Siemiatkowski M, Maciejak P, Szyndler J, Plaznik A (2000): The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia. J Neural Transm 107: 1403–1412.
   PubMed Web of Science ®Google Scholar
• Srikumar BN, Raju TR, Shankaranarayana Rao BS (2006): The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats. Neuroscience 143: 679–688.
   PubMedGoogle Scholar
• Srikumar BN, Raju TR, Shankaranarayana Rao BS (2007): Contrasting effects of bromocriptine on learning of a partially baited radial arm maze task in the presence and absence of restraint stress. Psychopharmacology (Berl) 193: 363–374.
   PubMedGoogle Scholar
• Sunanda Shankaranarayana, Rao BS, Raju TR (2000): Restraint stress-induced alterations in the levels of biogenic amines, amino acids, and AChE activity in the hippocampus. Neurochem Res 25: 1547–1552.
   PubMedGoogle Scholar
• Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M (2000): Evidence that total extract of hypericum perforatum affects exploratory behavior and exerts anxiolytic effect in rats. Pharmacol Biochem Behav 65: 627–633.
   PubMed Web of Science ®Google Scholar
• Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S (2002): Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22: 6810–6818.
   PubMed Web of Science ®Google Scholar
• Weiner MF, Svetlik D, Risser RC (1997): What depressive symptoms are reported in Alzheimer’s patients? Int J Geriatr Psychiatry 12: 648–652.
   PubMedGoogle Scholar